Elevated heart rate increases microalbuminuria risk in diabetics, finds study

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2021-01-01 10:15 GMT | Update On 2021-01-02 07:51 GMT

Taiwan: Increased resting heart rate is associated with an increased risk of microalbuminuria development in type 2 diabetes (T2D) patients, finds a recent study in the journal Diabetic Medicine.

Microalbuminuria is an indicative of chronic kidney disease and adverse cardiovascular events. Studies have showed elevated resting heart rate to be a risk factor for microalbuminuria in cardiovascular disease patients but its role in the microalbuminuria development in T2D patients is not clarified yet. Y.K. Chang, Jenteh Junior College of Medicine, Nursing and Management, Miaoli, Taiwan, and colleagues therefore investigated the relationship between resting heart rate and new‐onset microalbuminuria in type 2 diabetes.

The prospective cohort study enrolled a total of 788 people from a glycemic control trial in Taiwan. The resting heart rate and other covariates were measured at baseline. Microalbuminuria was defined as a fasting urine albumin‐to‐creatinine ratio ≥30 mg/g in two consecutive urine tests. The quartile of resting heart rates, categorized as <70, 70‐74, 75‐80, and >80 beats/min. The association between resting heart rate and risk of microalbuminuria were evaluated using Cox proportional hazard models.

Key findings of the study include:

During the follow‐up period, 31% people developed microalbuminuria.
Those who developed microalbuminuria had a longer diabetes duration (median=3.0 vs. 2.0 years), higher rate of hypertension (77% vs. 66%), higher rate of ACE inhibitor/angiotensin receptor blocker treatment (50% vs. 38%), and higher baseline HbA1c level (70 vs. 64 mmol/mol, 8.6 vs. 8.0 %).
After adjusting for demographics, metabolic profiles, and inflammatory markers, developing microalbuminuria was significantly associated with baseline resting heart rate of 70‐74, 75‐80, and >80 beats/min (with hazard ratios of 2.05, 2.10, and 1.62, respectively) compared to resting heart rates <70 beats/min.
An average increased risk of microalbuminuria for increment of 10 beats/min was about 24% among those with hypertension (with hazard ratios of 1.24 in the multivariable Cox model).

"Our results showed resting heart rate may be an associative risk factor for developing microalbuminuria in type 2 diabetes," concluded the authors.

"The relationship between resting heart rate and new‐onset microalbuminuria in people with type 2 diabetes: An eight‐year follow‐up study," is published in the journal Diabetic Medicine.

DOI: https://onlinelibrary.wiley.com/doi/abs/10.1111/dme.14436

Article Source : Diabetic Medicine

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Medha Baranwal

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Elevated heart rate increases microalbuminuria risk in diabetics, finds study

Similar News

Women With Pre-Pregnancy Chronic Conditions Face Greater Risk of Severe Maternal Complications: Study Shows

De-escalation of DAPT provides benefits in patients after CABG: ESC Study

Abelacimab Cuts Bleeding Risk in AF Patients Regardless of Kidney Function: AZALEA-TIMI 71 Analysis

Post MI Beta blockers may offer no benefit for heart attack patients and women can have worse outcomes: ESC Study

WHO Expands 2025 Essential Medicines List, Adding Life-Saving Cancer and Diabetes Treatments

Monthly Olezarsen Significantly Lowers Triglycerides in High-Risk Patients: NEJM

GLP-1 Receptor Agonists Improve Metabolic Outcomes in Schizophrenia Patients on Antipsychotics: JAMA

Some mental conditions raise heart disease risk, mortality rate by nearly 100%, reveals study